X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
critical care medicine (2) 2
index medicus (2) 2
respiratory system (2) 2
abridged index medicus (1) 1
aeruginosa infection (1) 1
age (1) 1
aged 6-11 years (1) 1
children (1) 1
clinical trial (1) 1
clinical-trials (1) 1
counseling (1) 1
cystic fibrosis (1) 1
cystic fibrosis - nursing (1) 1
cystic fibrosis - physiopathology (1) 1
cystic fibrosis - psychology (1) 1
diagnosis (1) 1
disease (1) 1
efficacy (1) 1
eradication (1) 1
evolution (1) 1
exacerbations (1) 1
female (1) 1
growth (1) 1
humans (1) 1
impact (1) 1
infant, newborn (1) 1
infants (1) 1
inhaled tobramycin (1) 1
ivacaftor (1) 1
lung clearance index (1) 1
lung-disease (1) 1
malnutrition (1) 1
meconium ileus (1) 1
multiple-breath washout (1) 1
neonatal screening (1) 1
newborn (1) 1
nursing (1) 1
nutritional physiological phenomena (1) 1
obstetrics & gynecology (1) 1
original research (1) 1
patient education as topic (1) 1
pediatrics (1) 1
perinatal care (1) 1
preconception care (1) 1
pregnancy (1) 1
pregnancy complications - nursing (1) 1
pregnancy complications - physiopathology (1) 1
pregnancy complications - psychology (1) 1
pregnancy, complications of (1) 1
prenatal care (1) 1
prevention (1) 1
pseudomonas aeruginosa (1) 1
pulmonary exacerbation (1) 1
pulmonary-function (1) 1
research (1) 1
respiratory (1) 1
respiratory tract infections - prevention & control (1) 1
risk factors (1) 1
risk-factors (1) 1
spirometry (1) 1
women (1) 1
young-children (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 11/2018, Volume 198, Issue 9, pp. 1177 - 1187
Rationale: New isolation of Pseudomonas aeruginosa (Pa) is generally treated with inhaled antipseudomonal antibiotics such as tobramycin inhalation solution... 
clinical trial | pulmonary exacerbation | Pseudomonas aeruginosa | eradication | INHALED TOBRAMYCIN | RISK-FACTORS | AERUGINOSA INFECTION | PULMONARY-FUNCTION | RESPIRATORY SYSTEM | CLINICAL-TRIALS | EXACERBATIONS | LUNG-DISEASE | YOUNG-CHILDREN | AGE | CRITICAL CARE MEDICINE | Original Research
Journal Article
by Ratjen, Felix and Davis, Miriam and Davis, Stephanie and Davis, Stephanie D and Stanojevic, Sanja and Kronmal, Richard A and Hinckley Stukovsky, Karen D and Jorgensen, Neal and Rosenfeld, Margaret and Kerby, Gwen and Kopecky, Carol and Anthony, Meg and Mogayzel, Peter and Walker, Betty and Walker, Doug and Zeglin, Britany and Hoover, Wynton and Hathorne, Heather and Slaten, Katie and Dorkin, Henry (Hank) and Fowler, Robert and Fenton, Cole (Nicolas) and Ulles, Monica and Goetz, Danielle and Caci, Nadine and Cahill, Beth and Roach, Christine and Retsch-Bogart, George and Johnson, Robin and Johnson, Terri and Cunnion, Rose and McColley, Susanna and Ward, Steven and Bell, Emily and McPhail, Gary and Keller, Kimberly and Thornton, Kelly and Parsons, Ashlee and Chmiel, James and Schaefer, Cindy and Tribout, Megan and Tribout, Heather and Consiglio, Brittany and McCoy, Karen and Olson, Patti and Raterman, Laura and Hiatt, Peter and Schaap, Nicoline and Clem, Charles and Bendy, Lisa and Starner, Tim and Lux, Cheri and Carver, Terrence and Thompson, Rose and Williams, April and Schmoll, Candy and Hastings, Patricia M and Noe, Julie and Roth, Laura and Kump, Theresa and McNamara, John and McNamara, Sharon and Franck Thompson, Elizabeth and Yousef, Shatha and Wezel, Germaine (Gigi) and Oquendo, Omar and Darling, Amanda and Valencia, Wendy and Milla, Carlos and Zirbes, Jackie and Rubenstein, Ronald and Donnelly, Erin and Malpass, Jean and Weiner, Daniel and Agostini, Brittani and Hartigan, Elizabeth and Cornell, Alexandra and Klein, Brendan and Bucher, Jenna and Nusbaum, Pierce and Genatossio, Alan and Pittman, Jessica and Hicks, Tina and Bauer, Irma and Siegel, Molly and Isaac, Sarah and Jensen, Renee and Au, Jacky and McDonald, Nancy and Prentice, Carley and Chilvers, Mark and Richmond, Melissa and SHIP Study Grp and SHIP Study Group
The Lancet Respiratory Medicine, ISSN 2213-2600, 09/2019, Volume 7, Issue 9, pp. 802 - 809
Inhaled hypertonic saline enhances mucociliary clearance, improves lung function, and reduces pulmonary exacerbations in people with cystic fibrosis older than... 
DIAGNOSIS | EVOLUTION | IVACAFTOR | EFFICACY | RESPIRATORY SYSTEM | INFANTS | DISEASE | MULTIPLE-BREATH WASHOUT | AGED 6-11 YEARS | SPIROMETRY | LUNG CLEARANCE INDEX | CRITICAL CARE MEDICINE
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.